⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALEC News
Alector, Inc. Common Stock
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
globenewswire.com
ALEC
FASTPACE Expands C-PACE Partnership Network with Addition of SustainEnergyFinance, Utah's Green Bank
accessnewswire.com
ALEC
Form 8-K
sec.gov
ALEC
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
ALEC
Alector to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
ALEC
Middle East Prefabricated Construction Industry Report 2025: Megaproject Demand, Vision 2030 and Digital Infrastructure Accelerate Off-Site Adoption - Forecast to 2029
globenewswire.com
ALEC
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint
prnewswire.com
ALEC
Adimab Reports Strong Partnering Year for 2025
prnewswire.com
ALNY
NVO
MRK
LLY
REGN
VRTX
AZN
GSK
BIIB
SCHR
ALEC
Levi & Korsinsky Announces an Investigation on Behalf of Alector, Inc. (ALEC) Shareholders Who May Have Been Affected by Fraud
accessnewswire.com
ALEC
Alector, Inc. (ALEC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
accessnewswire.com
ALEC